Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Borregaard Board/Management Information 2025

Jun 13, 2025

3562_rns_2025-06-13_f0869032-9f64-404b-bbcd-6367c1576e89.html

Board/Management Information

Open in viewer

Opens in your device viewer

Borregaard ASA: Change in Group Executive Management

Borregaard ASA: Change in Group Executive Management

Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August

2025. He will also join the Group Executive Management on the same date. Bakke

succeeds Tom Erik Foss-Jacobsen, who will assume the role of CEO on 1 August

(see stock exchange release dated 23 May 2025).

Bakke currently serves as Director of Investor Relations and has previously held

the position of Energy Director at Borregaard. Prior to joining the company in

2019, he held senior leadership roles at Norsk Hydro, where he was responsible

for global energy market operations. He holds an MSc in Industrial Economics and

Technology Management from the Norwegian University of Science and Technology

(NTNU).

Borregaard will initiate a process to appoint a new Director of Investor

Relations. In the interim, CFO Per Bjarne Lyngstad will assume the

responsibility from 1 August.

Contacts:

Dag Arthur Aasbø, SVP Organisation and Public Affairs, +47 918 34 108

Per Bjarne Lyngstad, CFO, +47 952 44 515

This information is subject to the disclosure requirements pursuant to Section

5-12 of the Norwegian Securities Trading Act.